用灭活的利什曼原虫前鞭毛体免疫后对黑山抗原的反应。 - Suppr | 超能文献

Responses to Montenegro antigen after immunization with killed Leishmania promastigotes.

作者信息

Mayrink W, Magalhães P A, Dias M, Da Costa C A, Melo M N, Lima A O

出版信息

Trans R Soc Trop Med Hyg. 1978;72(6):676. doi: 10.1016/0035-9203(78)90041-x.

DOI:10.1016/0035-9203(78)90041-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Responses to Montenegro antigen after immunization with killed Leishmania promastigotes.用灭活的利什曼原虫前鞭毛体免疫后对黑山抗原的反应。

Trans R Soc Trop Med Hyg. 1978;72(6):676. doi: 10.1016/0035-9203(78)90041-x.

2

A field trial of a vaccine against American dermal leishmaniasis.

Trans R Soc Trop Med Hyg. 1979;73(4):385-7. doi: 10.1016/0035-9203(79)90159-7.

3

An experimental vaccine against American dermal leishmaniasis: experience in the State of Espírito Santo, Brazil.一种针对美洲皮肤利什曼病的实验性疫苗：在巴西圣埃斯皮里图州的经验。

Ann Trop Med Parasitol. 1985 Jun;79(3):259-69. doi: 10.1080/00034983.1985.11811917.

4

Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.在感染巴西利什曼原虫（维安尼亚种）的小鼠模型中对四种利什曼原虫疫苗候选物进行测试，巴西利什曼原虫（维安尼亚种）是新世界皮肤利什曼病的主要病原体。

Clin Vaccine Immunol. 2007 Sep;14(9):1173-81. doi: 10.1128/CVI.00060-07. Epub 2007 Jul 11.

5

Control of the leishmaniases. Report of a WHO Expert Committee.利什曼病的防治。世界卫生组织专家委员会报告。

World Health Organ Tech Rep Ser. 1990;793:1-158.

6

[ON THE MONTENEGRO INTRADERMOREACTION IN THE REGION OF ENDEMIC TEGUMENTAL AND VISCERAL LEISHMANIASIS].[关于黑山地区内脏利什曼病和皮肤利什曼病流行区的贸易商更多行动]

Rev Inst Med Trop Sao Paulo. 1963 Jul-Aug;5:170-5.

7

[Results of Montenegro's reaction in patients with mucocutaneous leishmaniasis, from Espírito Santo state].

AMB Rev Assoc Med Bras. 1991 Jul-Sep;37(3):115-8.

8

Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis.巨噬细胞利什曼原虫受体免疫可保护小鼠免受皮肤利什曼病感染。

Proc Natl Acad Sci U S A. 1985 Sep;82(17):5910-4. doi: 10.1073/pnas.82.17.5910.

9

Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.鼠模型中皮肤利什曼病的疫苗接种。I. 前鞭毛体可溶性提取物诱导保护性免疫

J Immunol. 1987 Jul 1;139(1):221-7.

10

[Current aspects of endemic mucocutaneous leishmaniasis in Brazil].[巴西地方性黏膜皮肤利什曼病的当前状况]

Hautarzt. 1985 Sep;36(9):531-3.

引用本文的文献

1

A review of the leishmanin skin test: A neglected test for a neglected disease.利什曼素皮试评价：被忽视疾病的被忽视检测。

PLoS Negl Trop Dis. 2021 Jul 22;15(7):e0009531. doi: 10.1371/journal.pntd.0009531. eCollection 2021 Jul.

2

A follow-up study (2007-2018) on American Tegumentary Leishmaniasis in the municipality of Caratinga, Minas Gerais State, Brazil: Spatial analyses and sand fly collection.巴西米纳斯吉拉斯州卡拉廷加市美国皮肤利什曼病的后续研究（2007-2018 年）：空间分析和沙蝇采集。

PLoS Negl Trop Dis. 2021 May 18;15(5):e0009429. doi: 10.1371/journal.pntd.0009429. eCollection 2021 May.

3

Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses.人类针对皮肤利什曼病的疫苗接种：细胞免疫和体液免疫反应。

Infect Immun. 1990 Jul;58(7):2198-203. doi: 10.1128/iai.58.7.2198-2203.1990.